A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 20, Issue SUPPL.2, 2010, Pages

  Santos, Renato X ^a,b   Correia, Sónia C ^a,b   Wang, Xinglong ^c   Perry, George ^c,d   Smith, Mark A ^c   Moreira, Paula I ^a,e   Zhu, Xiongwei ^c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^e UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Alzheimer's disease; fission; fusion; mitochondrial dysfunction; mitophagy

Indexed keywords

AMYLOID BETA PROTEIN; CYCLOPHILIN D; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; AUTOPHAGY; BRAIN MITOCHONDRION; CELL DIVISION; CELL FUSION; CELL ORGANELLE; CELL STRUCTURE; DEMENTIA; DISEASE COURSE; ENZYME ACTIVITY; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR DYNAMICS; NERVE CELL NECROSIS; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; RESPIRATORY CHAIN; REVIEW; SENILE PLAQUE; SIGNAL TRANSDUCTION;

EID: 77956199031     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100666     Document Type: Review

References (147)

1. Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362, 329-344.
2. Su B, Wang X, Bonda D, Perry G, Smith M, Zhu X (2010) Abnormal mitochondrial dynamics-a novel therapeutic target for Alzheimer's disease? Mol Neurobiol, in press.
3. Smith MA (1998) Alzheimer disease. Int Rev Neurobiol 42, 1-54.
4. Slow EJ, Graham RK, Hayden MR (2006) To be or not to be toxic: aggregations in Huntington and Alzheimer disease. Trends Genet 22, 408-411.
5. Glabe CG, Kayed R (2006) Common structure and toxic function ofamyloid oligomers implies a common mechanism of pathogenesis. Neurology 66, S74-78.
6. Swerdlow RH, Khan SM (2004) A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. MedHypothe- ses 63, 8-20.
7. Swerdlow RH, Khan SM (2009) The Alzheimer's disease mitochondrial cascade hypothesis: an update. Exp Neurol 218, 308-315.
8. Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M, Leuner K, Eckert A, Muller WE (2009) Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging 30, 1574-1586.
9. Smith MA, Sayre LM, Monnier VM, Perry G (1995) Radical AGEing in Alzheimer's disease. Trends Neurosci 18, 172176.
10. Humpel C, Marksteiner J (2005) Cerebrovascular damage as a cause for Alzheimer's disease. Curr Neurovasc Res 2, 341-347.
11. Brenner SR (2008) Neurovascular unit dysfunction: avascular component of Alzheimer disease? Neurology 70, 243244.
12. Pei JJ, Sjogren M, Winblad B (2008) Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets. Curr Opin Psychiatry 21, 555-561.
13. Lee HG, Perry G, Moreira PI, Garrett MR, Liu Q, Zhu X, Takeda A, Nunomura A, Smith MA (2005) Tau phosphory- lation in Alzheimer's disease: pathogen or protector? Trends Mol Med 11, 164-169.
14. Chung SH (2009) Aberrant phosphorylation in the pathogen- esis of Alzheimer's disease. BMB Rep 42, 467-474.
15. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
16. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. NatRevMol Cell Biol 8, 101-112.
17. Korczyn AD (2008) The amyloid cascade hypothesis. Alzheimers Dement 4, 176-178.
18. Celsi F, Pizzo P, Brini M, Leo S, Fotino C, Pinton P, Rizzuto R (2009) Mitochondria, calcium and cell death: a deadly triad in neurodegeneration. Biochim Biophys Acta 1787, 335-344.
19. Newmeyer DD, Ferguson-Miller S (2003) Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112, 481-490.
20. Moreira PI, Duarte AI, Santos MS, Rego AC, Oliveira CR (2009) An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease. J Alzheimers Dis 16, 741-761.
21. Balaban RS, Nemoto S, Finkel T (2005) Mitochondria, oxi- dants, and aging. Cell 120, 483-495.
22. Wei YH, Wu SB, Ma YS, Lee HC (2009) Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging. Chang Gung MedJ 32, 113-132.
23. Harman D (2003) The free radical theory of aging. Antioxid Redox Signal 5, 557-561.
24. Kann O, Kovacs R (2007) Mitochondria and neuronal activity. Am J Physiol Cell Physiol 292, C641-657.
25. Chan DC (2006) Mitochondria: dynamic organelles in disease, aging, and development. Cell 125, 1241-1252.
26. Blass JP (2000) The mitochondrial spiral. An adequate cause of dementia in the Alzheimer's syndrome. Ann N YAcad Sci 924, 170-183.
27. Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795.
28. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Bal- raj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA (2001) Ox- idative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60, 759-767.
29. Reddy PH, Beal MF (2005) Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Brain Res Rev 49, 618-632.
30. Moreira PI, Carvalho C, Zhu X, Smith MA, Perry G (2010) Mitochondrial dysfunction is a trigger ofAlzheimer's disease pathophysiology. Biochim Biophys Acta 1802, 2-10.
31. Parker WD, Jr. (1991) Cytochrome oxidase deficiency in Alzheimer's disease. Ann N Y Acad Sci 640, 59-64.
32. Maurer I, Zierz S, Moller HJ (2000) A selective defect of cytochrome c oxidase is present in brain ofAlzheimer disease patients. Neurobiol Aging 21, 455-462.
33. Chen H, McCaffery JM, Chan DC (2007) Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 130, 548-562.
34. Cheng X, Kanki T, Fukuoh A, Ohgaki K, Takeya R, Aoki Y, Hamasaki N, Kang D (2005) PDIP38 Associates with Proteins Constituting the Mitochondrial DNA Nucleoid. J Biochem (Tokyo) 138, 673-678.
35. Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, Alroy J, Wu M, Py BF, Yuan J, Deeney JT, Corkey BE, Shirihai OS (2008) Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 27, 433-446.
36. Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417, 1-13.
37. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39, 44-84.
38. Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82, 47-95.
39. Afanas'ev IB (2007) Signaling functions of free radicals superoxide & nitric oxide under physiological & pathological conditions. Mol Biotechnol 37, 2-4.
40. Addabbo F, Montagnani M, Goligorsky MS (2009) Mitochondria and reactive oxygen species. Hypertension 53, 885892.
41. Starkov AA (2008) The role of mitochondria in reactive oxygen species metabolism and signaling. Ann N Y Acad Sci 1147, 37-52.
42. Resende R, Moreira PI, Proenca T, Deshpande A, Busciglio J, Pereira C, Oliveira CR (2008) Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med 44, 2051-2057.
43. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brin- ton RD (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 106, 1467014675.
44. Russell RL, Siedlak SL, Raina AK, Bautista JM, Smith MA, Perry G (1999) Increased neuronal glucose-6-phosphate de- hydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. Arch Biochem Biophys 370, 236-239.
45. Fukui H, Diaz F, Garcia S, Moraes CT (2007) Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 104, 14163-14168.
46. Hansson Petersen CA, Alikhani N, Behbahani H, Wiehager B, Pavlov PF, Alafuzoff I, Leinonen V, Ito A, Winblad B, Glaser E, Ankarcrona M (2008) The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci U SA 105, 13145-13150.
47. Atamna H, Frey WH, 2nd (2004) A role for heme in Alzheimer's disease: heme binds amyloid beta and has altered metabolism. Proc Natl Acad Sci USA 101, 1115311158.
48. Atamna H (2006) Heme binding to Amyloid-beta peptide: mechanistic role in Alzheimer's disease. J Alzheimers Dis 10, 255-266.
49. Takuma K, Yao J, Huang J, Xu H, Chen X, Luddy J, Tril- lat AC, Stern DM, Arancio O, Yan SS (2005) ABAD en hances Abeta-induced cell stress via mitochondrial dysfunction. FASEBJ 19, 597-598.
50. Dell'agnello C, Leo S, Agostino A, Szabadkai G, Tiveron C, Zulian A, Prelle A, Roubertoux P, Rizzuto R, Zeviani M (2007) Increased longevity and refractoriness to Ca(2+)- dependent neurodegeneration in Surf1 knockout mice. Hum Mol Genet 16,431-444.
51. Devi L, Prabhu BM, Galati DF, Avadhani NG, Anan- datheerthavarada HK (2006) Accumulation of amyloid precursor protein in the mitochondrial import channels ofhuman Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 26, 9057-9068.
52. Fattoretti P, Balietti M, Casoli T, Giorgetti B, Di Stefano G, Bertoni-Freddari C, Lattanzio F, Sensi SL (2010) Decreased numeric density of succinic dehydrogenase-positive mitochondria in CA1 pyramidal neurons of 3xTg-AD mice. Rejuvenation Res 13, 144-147.
53. Rhein V, Song X, Wiesner A, Ittner LM, Baysang G, Meier F, Ozmen L, Bluethmann H, Drose S, Brandt U, Savaskan E, Czech C, Gotz J, Eckert A (2009) Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci USA 106, 20057-20062.
54. Rizzuto R, Bernardi P, Pozzan T (2000) Mitochondria as all-round players of the calcium game. J Physiol 529 Pt 1, 37-47.
55. Zimmermann H (1990) Neurotransmitter release. FEBSLett 268, 394-399.
56. Rizzuto R, Pinton P, Brini M, Chiesa A, Filippin L, Pozzan T (1999) Mitochondria as biosensors of calcium microdomains. Cell Calcium 26, 193-199.
57. Zucker RS (1999) Calcium- and activity-dependent synaptic plasticity. Curr Opin Neurobiol 9, 305-313.
58. Soderling TR (2000) CaM-kinases: modulators of synaptic plasticity. Curr OpinNeurobiol 10, 375-380.
59. Sabatini BL, Maravall M, Svoboda K (2001) Ca(2+) signaling in dendritic spines. Curr Opin Neurobiol 11, 349-356.
60. Wojda U, Salinska E, Kuznicki J (2008) Calcium ions in neuronal degeneration. IUBMB Life 60, 575-590.
61. Moreira PI, Santos MS, Moreno A, Oliveira C (2001) Amyloid beta-peptide promotes permeability transition pore in brain mitochondria. Biosci Rep 21, 789-800.
62. Moreira PI, Santos MS, Moreno A, Rego AC, Oliveira C Effect ofamyloid beta-peptide on permeability transition pore: a comparative study. J Neurosci Res 69, 257-267.
63. Moreira PI, Santos MS, Moreno AM, Seica R, Oliveira CR Increased vulnerability of brain mitochondria in diabetic (Goto-Kakizaki) rats with aging and amyloid-beta exposure. Diabetes 52, 1449-1456.
64. Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, Yan Y, Wang C, Zhang H, Molkentin JD, Gunn-Moore FJ, Vonsattel JP, Arancio O, Chen JX, Yan SD (2008) Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med 14, 1097-1105.
65. Wallace DC, Stugard C, Murdock D, Schurr T, Brown MD (1997) Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations. Proc Natl Acad Sci USA 94, 1490014905.
66. Coskun PE, Beal MF, Wallace DC (2004) Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci USA 101, 10726-10731.
67. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, Young IG (1981) Sequence and organization ofthe human mitochondrial genome. Nature 290, 457-465.
68. Ribe EM, Serrano-Saiz E, Akpan N, Troy CM (2008) Mechanisms of neuronal death in disease: defining the models and the players. Biochem J 415, 165-182.
69. Yang TT, Hsu CT, Kuo YM (2009) Amyloid precursor protein, heat-shock proteins, and Bcl-2 form a complex in mitochondria and modulate mitochondria function and apoptosis in N2a cells. Mech Ageing Dev 130, 592-601.
70. Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E (2008) Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 9, 505-518.
71. Baloh RH, Schmidt RE, Pestronk A, Milbrandt J (2007) Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations. J Neurosci 27, 422-430.
72. Hoppins S, Lackner L, Nunnari J (2007) The machines that divide and fuse mitochondria. Annu Rev Biochem 76, 751780.
73. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC (2003) Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 160, 189-200.
74. Barsoum MJ, Yuan H, Gerencser AA, Liot G, Kushnareva Y, Graber S, Kovacs I, Lee WD, Waggoner J, Cui J, White AD, Bossy B, Martinou JC, Youle RJ, Lipton SA, Ellisman MH, Perkins GA, Bossy-Wetzel E (2006) Nitric oxide-induced mi- tochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 25, 3900-3911.
75. Su B, Wang X, Zheng L, Perry G, Smith MA, Zhu X (2010) Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim Biophys Acta 1802, 135-142.
76. Smirnova E, Griparic L, Shurland DL, van der Bliek AM (2001) Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell 12, 2245-2256.
77. James DI, Parone PA, Mattenberger Y, Martinou JC (2003) hFis1, a novel component of the mammalian mitochondrial fission machinery. J Biol Chem 278, 36373-36379.
78. Chen H, Chomyn A, Chan DC (2005) Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem 280,26185-26192.
79. Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, Zappia M, Nelis E, Patitucci A, Senderek J, Parman Y, Evgrafov O, Jonghe PD, Takahashi Y, Tsuji S, Pericak-Vance MA, Quattrone A, Battaloglu E, Polyakov AV, Timmerman V, Schroder JM, Vance JM (2004) Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 36, 449-451.
80. Ishihara N, Fujita Y, Oka T, Mihara K (2006) Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J 25, 2966-2977.
81. Cipolat S, Martins de Brito O, Dal Zilio B, Scorrano L (2004) OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc Natl Acad Sci USA 101, 15927-15932.
82. Chang CR, Blackstone C (2007) Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology. J Biol Chem 282, 21583-21587.
83. Cribbs JT, Strack S (2007) Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and cal- cineurin regulates mitochondrial fission and cell death. EM- BO Rep 8, 939-944.
84. Taguchi N, Ishihara N, Jofuku A, Oka T, Mihara K (2007) Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem 282, 1152111529.
85. Nakamura N, Kimura Y, Tokuda M, Honda S, Hirose S (2006) MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. EMBO Rep 7, 1019-1022.
86. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, Gu Z, Lipton SA (2009) S-nitrosylation of Drp1 mediates beta- amyloid-related mitochondrial fission and neuronal injury. Science 324, 102-105.
87. Harder Z, Zunino R, McBride H (2004) Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission. Curr Biol 14, 340-345.
88. Song Z, Chen H, Fiket M, Alexander C, Chan DC (2007) OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J Cell Biol 178, 749-755.
89. Griparic L, Kanazawa T, van der Bliek AM (2007) Regulation of the mitochondrial dynamin-like protein Opa1 by proteolytic cleavage. J Cell Biol 178, 757-764.
90. Ehses S, Raschke I, Mancuso G, Bernacchia A, Geimer S, Tondera D, Martinou JC, Westermann B, Rugarli EI, Langer T (2009) Regulation ofOPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1. J Cell Biol 187, 1023-1036.
91. Duvezin-Caubet S, Jagasia R, Wagener J, Hofmann S, Tri- funovic A, Hansson A, Chomyn A, Bauer MF, Attardi G, Larsson NG, Neupert W, Reichert AS (2006) Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J Biol Chem 281, 37972-37979.
92. Baricault L, Segui B, Guegand L, Olichon A, Valette A, Larminat F, Lenaers G (2007) OPA1 cleavage depends on decreased mitochondrial ATP level and bivalent metals. Exp Cell Res 313, 3800-3808.
93. Guillery O, Malka F, Landes T, Guillou E, Blackstone C, Lombes A, Belenguer P, Arnoult D, Rojo M (2008) Metalloprotease-mediated OPA1 processing is modulated by the mitochondrial membrane potential. Biol Cell 100, 315325.
94. Cherra SJ, Chu CT (2008) Autophagy in neuroprotection and neurodegeneration: A question ofbalance. Future Neurol 3, 309-323.
95. Chu CT (2006) Autophagic stress in neuronal injury and disease. J Neuropathol Exp Neurol 65, 423-432.
96. Xie Z, Klionsky DJ (2007) Autophagosome formation: core machinery and adaptations. Nat Cell Biol 9, 1102-1109.
97. Yang Z, Klionsky DJ (2010) Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 22, 124-131.
98. Hamasaki M, Yoshimori T (2010) Where do they come from? Insights into autophagosome formation. FEBS Lett 584, 1296-1301.
99. Pattingre S, Espert L, Biard-Piechaczyk M, Codogno P (2008) Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 90, 313-323.
100. Todde V, Veenhuis M, van der Klei IJ (2009) Autophagy: principles and significance in health and disease. Biochim Biophys Acta 1792, 3-13.
101. Eskelinen EL (2008) New insights into the mechanisms of macroautophagy in mammalian cells. Int Rev Cell Mol Biol 266, 207-247.
102. Kamada Y, Funakoshi T, Shintani T, Nagano K, Ohsumi M, Ohsumi Y (2000) Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J Cell Biol 150, 1507-1513.
103. Hara T, Mizushima N (2009) Role of ULK-FIP200 complex in mammalian autophagy: FIP200, a counterpart of yeast Atg17? Autophagy 5, 85-87.
104. Hosokawa N, Sasaki T, Iemura S, Natsume T, Hara T, MizushimaN (2009) Atg101, anovel mammalian autophagy protein interacting with Atg13. Autophagy 5, 973-979.
105. Mercer CA, Kaliappan A, Dennis PB (2009) A novel, human Atg13 binding protein, Atg101, interacts with ULK1 and is essential for macroautophagy. Autophagy 5, 649-662.
106. Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, Bi- langes B (2010) The emerging mechanisms of isoform- specific PI3K signalling. Nat Rev Mol Cell Biol 11, 329-341.
107. Kundu M, Thompson CB (2008) Autophagy: basic principles and relevance to disease. Annu Rev Pathol 3, 427-455.
108. Reggiori F (2006) 1. Membrane origin for autophagy. Curr TopDevBiol 74, 1-30.
109. Nishida Y, Arakawa S, Fujitani K, Yamaguchi H, Mizuta T, Kanaseki T, Komatsu M, Otsu K, Tsujimoto Y, Shimizu S (2009) Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 461, 654-658.
110. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, Tashiro Y (1998) Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophago- somes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct 23, 33-42.
111. Jager S, Bucci C, Tanida I, Ueno T, Kominami E, Saftig P, Eskelinen EL (2004) Role for Rab7 in maturation of late autophagic vacuoles. J Cell Sci 117, 4837-4848.
112. Eskelinen EL (2005) Maturation of autophagic vacuoles in Mammalian cells. Autophagy 1, 1-10.
113. Lemasters JJ (2005) Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res 8, 3-5.
114. Tolkovsky AM (2009) Mitophagy. Biochim Biophys Acta 1793, 1508-1515.
115. Kanki T, Wang K, Cao Y, Baba M, Klionsky DJ (2009) Atg32 is a mitochondrial protein that confers selectivity during mi- tophagy. Dev Cell 17, 98-109.
116. Kanki T, Klionsky DJ (2008) Mitophagy in yeast occurs through a selective mechanism. J Biol Chem 283, 3238632393.
117. Okamoto K, Kondo-Okamoto N, Ohsumi Y (2009) Mitochondria-anchored receptor Atg32 mediates degradation of mitochondria via selective autophagy. Dev Cell 17, 87-97.
118. Priault M, Salin B, Schaeffer J, Vallette FM, di Rago JP, Martinou JC (2005) Impairing the bioenergetic status and the biogenesis of mitochondria triggers mitophagy in yeast. Cell Death Differ 12, 1613-1621.
119. Nowikovsky K, Reipert S, Devenish RJ, Schweyen RJ (2007) Mdm38 protein depletion causes loss of mitochondrial K+/H+ exchange activity, osmotic swelling and mitophagy. Cell Death Differ 14, 1647-1656.
120. Deffieu M, Bhatia-Kissova I, Salin B, Galinier A, Manon S, Camougrand N (2009) Glutathione participates in the regulation of mitophagy in yeast. J Biol Chem 284, 14828-14837.
121. Elmore SP, Qian T, Grissom SF, Lemasters JJ (2001) The mitochondrial permeability transition initiates autophagy in rat hepatocytes. FASEBJ15, 2286-2287.
122. Kim I, Rodriguez-Enriquez S, Lemasters JJ (2007) Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 462, 245-253.
123. Rodriguez-Hernandez A, Cordero MD, Salviati L, Artuch R, Pineda M, Briones P, Gomez Izquierdo L, Cotan D, Navas P, Sanchez-Alcazar JA (2009) Coenzyme Q deficiency triggers mitochondria degradation by mitophagy. Autophagy 5, 1932.
124. Navratil M, Terman A, Arriaga EA (2008) Giant mitochondria do not fuse and exchange their contents with normal mitochondria. Exp Cell Res 314, 164-172.
125. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, At- wood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shi- mohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21, 3017-3023.
126. Baloyannis SJ (2006) Mitochondrial alterations in Alzheimer's disease. J Alzheimers Dis 9, 119-126.
127. Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB, Gonzalez FJ, Semenza GL (2008) Mitochondri- al autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 283, 10892-10903.
128. Pan T, Rawal P, Wu Y, Xie W, Jankovic J, Le W (2009) Rapamycin protects against rotenone-induced apoptosis through autophagy induction. Neuroscience 164, 541-551.
129. Ditaranto K, Tekirian TL, Yang AJ (2001) Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease. Neurobiol Dis 8, 19-31.
130. Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA (2008) Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J Neurosci 28, 6926-6937.
131. Ling D, Song HJ, Garza D, Neufeld TP, Salvaterra PM (2009) Abeta42-induced neurodegeneration via an age-dependent autophagic-lysosomal injury in Drosophila. PLoS One 4, e4201.
132. Zheng L, Kagedal K, Dehvari N, Benedikz E, Cowburn R, Marcusson J, Terman A (2009) Oxidative stress induces macroautophagy of amyloid beta-protein and ensuing apop- tosis. Free Radic Biol Med 46, 422-429.
133. Yang AJ, Chandswangbhuvana D, Margol L, Glabe CG (1998) Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis. J Neurosci Res 52, 691-698.
134. Ma R, Xiong N, Huang C, Tang Q, Hu B, Xiang J, Li G (2009) Erythropoietin protects PC12 cells from beta-amyloid(25- 35)-induced apoptosis via PI3K/Akt signaling pathway. Neuropharmacology 56, 1027-1034.
135. Abbott JJ, Howlett DR, Francis PT, Williams RJ (2008) Abeta(1-42) modulation of Akt phosphorylation via alpha7 nAChR and NMDA receptors. Neurobiol Aging 29, 9921001.
136. Chiang HC, Wang L, Xie Z, Yau A, Zhong Y (2010) PI3 kinase signaling is involved in Abeta-induced memory loss in Drosophila. Proc Natl Acad Sci USA 107, 7060-7065.
137. Griffin RJ, Moloney A, Kelliher M, Johnston JA, Ravid R, Dockery P, O'Connor R, O'Neill C (2005) Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J Neurochem 93, 105-117.
138. Rickle A, Bogdanovic N, Volkmann I, Zhou X, Pei JJ, Win- blad B, Cowburn RF (2006) PTEN levels in Alzheimer's disease medial temporal cortex. Neurochem Int 48, 114-123.
139. Nakagami Y (2004) Inhibitors beta-amyloid-induced toxic- ity by modulating the Akt signaling pathway. Drug News Perspect 17, 655-660.
140. Rickle A, Bogdanovic N, Volkman I, Winblad B, Ravid R, Cowburn RF (2004) Akt activity in Alzheimer's disease and other neurodegenerative disorders. Neuroreport 15, 955-959.
141. Li X, Alafuzoff I, Soininen H, Winblad B, Pei JJ (2005) Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain. FEBSJ 272, 4211-4220.
142. An WL, Cowburn RF, Li L, Braak H, Alafuzoff I, Iqbal K, Iqbal IG, Winblad B, Pei JJ (2003) Up-regulation of phospho- rylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease. Am J Pathol 163, 591-607.
143. Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G (2007) Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy 3, 614-615.
144. Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G (2007) Autophagocytosis of mitochondria is prominent in Alzheimer disease. J Neuropathol Exp Neurol 66, 525-532.
145. Wang X, Su B, Fujioka H, Zhu X (2008) Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. Am J Pathol 173, 470-482.
146. Wang X, Su B, Zheng L, Perry G, Smith MA, Zhu X (2009) The role of abnormal mitochondrial dynamics in the patho- genesis of Alzheimer's disease. J Neurochem 109(Suppl 1), 153-159.
147. Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, Casadesus G, Zhu X (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation ofmitochondrial fission/fusion proteins. Proc Natl Acad Sci USA 105, 19318-19323.